| |
| |
|
| Insider
Information: |
Drutz David |
| Relationship: |
Director |
| City: |
Raleigh |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
20,151 |
|
|
Indirect Shares
|
29,785 |
|
|
| Direct
Value |
$145,490 |
|
|
|
Indirect Value
|
$215,048 |
|
|
| Total
Shares |
49,936 |
|
|
| Total
Value |
$360,538 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
4
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
4.0
|
0.0
|
| Percentage
Gain/Loss : |
 101.3%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Point Therapeutics Inc |
POTP |
Executive Chairman and... |
2015-12-04 |
0 |
2008-04-29 |
0 |
Premium* |
|
|
Altimmune, Inc |
ALT |
Director |
2022-11-18 |
20,151 |
2023-08-15 |
29,785 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
21 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALT |
Altimmune, Inc |
Director |
– • – |
2023-08-15 |
4 |
B |
$2.88 |
$863 |
I/I |
300 |
29,785 |
2.02 |
% |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2023-03-23 |
4 |
B |
$4.27 |
$38,430 |
I/I |
9,000 |
29,484 |
2.1 |
% |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2022-11-18 |
4 |
OE |
$2.40 |
$334 |
D/D |
139 |
20,151 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2022-06-15 |
4 |
B |
$8.00 |
$8,000 |
D/D |
1,000 |
20,012 |
2.39 |
% |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2022-05-24 |
4 |
B |
$4.50 |
$5,400 |
D/D |
1,200 |
19,012 |
2.39 |
% |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2022-01-25 |
4 |
OE |
$2.40 |
$168 |
D/D |
70 |
17,882 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2021-12-14 |
4 |
OE |
$2.40 |
$334 |
D/D |
139 |
17,812 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2021-11-19 |
4 |
OE |
$2.40 |
$168 |
D/D |
70 |
17,673 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2020-11-13 |
4 |
OE |
$2.40 |
$144 |
D/D |
60 |
17,603 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2020-09-24 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,850 |
17,543 |
0 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2017-08-23 |
4 |
B |
$2.27 |
$11,340 |
D/D |
5,000 |
30,777 |
2.39 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2017-08-22 |
4 |
B |
$2.15 |
$10,758 |
D/D |
5,000 |
25,777 |
2.39 |
- |
|
| ALT |
Altimmune, Inc |
Director |
– • – |
2017-05-04 |
4 |
A |
$0.00 |
$0 |
D/D |
20,777 |
20,777 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
Executive Chairman and CMO |
• • – |
2015-12-04 |
4 |
D |
$0.00 |
$0 |
D/D |
(20,614) |
0 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
CEO and CMO |
• • – |
2013-05-17 |
4 |
B |
$0.70 |
$17,440 |
D/D |
25,000 |
103,072 |
2.81 |
- |
|
| POTP |
Point Therapeutics Inc |
CEO and CMO |
• • – |
2012-09-17 |
4 |
B |
$1.06 |
$26,500 |
D/D |
25,000 |
78,073 |
2.81 |
- |
|
| POTP |
Point Therapeutics Inc |
CEO and CMO |
• • – |
2012-06-08 |
4 |
B |
$0.77 |
$19,250 |
D/D |
25,000 |
53,073 |
2.81 |
- |
|
| POTP |
Point Therapeutics Inc |
CEO and CMO |
• • – |
2012-05-29 |
4 |
B |
$0.90 |
$22,533 |
D/D |
25,000 |
28,073 |
2.81 |
- |
|
| POTP |
Point Therapeutics Inc |
Director |
– • – |
2010-01-04 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
49,167 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
Director |
– • – |
2009-01-08 |
4 |
A |
$0.00 |
$0 |
D/D |
4,167 |
39,167 |
0 |
- |
|
| POTP |
Point Therapeutics Inc |
Director |
– • – |
2008-04-29 |
4 |
A |
$0.00 |
$0 |
D/D |
35,000 |
35,000 |
0 |
- |
|
21 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
